TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/9/04 13:23 | 2/6/04 | ICRA | Incara Pharmaceuticals Corp | DE | Health | Drug | Pharmaceutical Preparations | Duncan Clayton I | NC | DO | CB,P,CEO | S | -30 | 0.3214 | 0 | -93 | -13 | 624 | D | ||||||||||||||
1/21/04 16:35 | 1/20/04 | ICRA | Incara Pharmaceuticals Corp | DE | Health | Drug | Pharmaceutical Preparations | Duncan Clayton I | NC | DO | CB,P,CEO | S | -9 | 0.3133 | 0 | -30 | -4 | 717 | D | ||||||||||||||
12/10/03 09:21 | 12/8/03 | INCR | Incara Pharmaceuticals Corp | DE | Health | Drug | Pharmaceutical Preparations | Duncan Clayton I | NC | DO | CB,P,CEO | S | -3 | 0.3000 | 0 | -10 | -1 | 747 | D | ||||||||||||||
12/4/03 10:36 | 12/2/03 | INCR | Incara Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Clayton I | NC | DO | CB,P,CEO | S | -6 | 0.3200 | 0 | -20 | -3 | 757 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |